Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately Euro32M, or 70%, by the End of 2025 vs FY 2022. May 25, 2023
LiveWire Ergogenics Reports First Quarter 2023 Financial Results Generates Fifth Consecutive Profitable Quarter May 19, 2023
Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income May 17, 2023